David R. Gifford - 20 Aug 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Aug 2026, 16:11:51 UTC
Prior SEC filing
17 Aug 2026
Next SEC filing
28 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David R. Gifford

Key filing fact

David R. Gifford filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 21 Aug 2026.

Key facts

  • This page summarizes David R. Gifford's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 21 Aug 2026, 16:11.

Change

  • Previous filing in this sequence was filed on 17 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002116347 Primary reporting owner

Gifford David R.

Relationship
Director
Address
100 VINE STREET, MURFREESBORO
Signature
/s/ David R. Gifford
Signature date
21 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHC transaction

Common Stock

Options Exercise

Transaction value
Shares
+6,479
Change %
+635%
Price
$171.42*
Shares after
7,500
Date
20 Aug 2026
Ownership
Direct
Footnotes
F1
NHC transaction

Common Stock

Award

Transaction value
Shares
-4,691
Change %
-63%
Price
$236.75*
Shares after
2,809
Date
20 Aug 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHC transaction Derivative

Option to Purchase Common Stock [2026 Grant]

Options Exercise

Transaction value
Shares
-6,479
Change %
-100%
Price
$0.000000*
Shares after
0
Date
20 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,479
Exercise price
$171.42
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

Footnote F2

Shares were withheld by the Company to pay the exercise price.

Footnote F3

Total amount of shares beneficially owned following transactions reported on this form.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .